Our proprietary NSM scaffold harnesses cellular biogenesis to generate precision-targeted natural nanoparticles (NNPs) that deliver diverse payloads directly to their intended sites
NNP Sorting Motif (NSM) Scaffold
NSM-based NNP Generation from Cells
Our proprietary NSM scaffold harnesses cellular biogenesis to generate
precision-targeted natural nanoparticles (NNPs) that deliver diverse payloads directly to their intended sites
NNP Sorting Motif (NSM) Scaffold
NSM-based NNP Generation from Cells
High design success rate | Multiplex cargo loading | Universal cell applications |
![]() | ![]() | ![]() |
Key Advantages
High design success rate | Multiplex cargo loading | Universal cell applications |
![]() | ![]() | ![]() |
NSM operates through protein-protein interactions (PPIs), enabling precise NNP design prediction using in silico molecular modeling
01
NSM structure modeling
02
Predicting NSM-based
NNP generation success rate
through PPI analysis
03
Refining NNP through
MD simulations
NSM operates through protein-protein interactions (PPIs),
enabling precise NNP design prediction using in silico molecular modeling
01
NSM structure modeling
02
Predicting NSM-based NNP generation success rate through PPI analysis
03
Refining NNP through
MD simulations
Traditional Drug Design Strategy | NNP Design AI™ Platform |
4–5 years or more | Period | A few months |
High | Cost | Low |
Complex experiments, repetitive validation | Process | Simple data analysis and prediction |
High | Failure Risk | Low (Risk mitigation) |
NNP Design AI™ predicts NSM-driven NNP generation,
enabling low-risk development of breakthrough delivery vehicles
Our platform enables us to develop NNPs that effectively deliver payloads to target organs/cells
Period | 4–5 years or more |
Cost | High |
Process | Complex experiments, repetitive validation |
NNP Design AI™ Platform
Period | A few months |
Cost | Low |
Process | Simple data analysis and prediction |
Failure Risk | Low (risk mitigation) |
NNP Design AI™ predicts
NSM-driven NNP generation,
enabling low-risk development
of breakthrough delivery vehicles
Our platform enables us to develop NNPs that effectively deliver payloads to target organs/cells